Literature DB >> 57964

Radioimmunoassay for serum thyroxine-binding globulin: results in normal subjects and in patients with hepatocellular carcinoma.

M C Gershengorn, P R Larsen, J Robbins.   

Abstract

Serum thyroxine-binding globulin (TBG) was measured by radioimmunoassay. The human TBG used in this study was purified by affinity, anion-exchange, and gel filtration chromatography. The serum TBG concentration in 98 euthyroid normals was 1.48 +/- 0.46 mg/100 ml (mean +/- SD), which is one-half that previously reported using a similar method. The level in females (1.66 +/- 0.56) was significantly higher than that in males (1.37 +/- 0.37). Comparison of the serum TBG level and the maximum binding capacity of serum TBG for thyroxine (T4) yielded a molar ratio of 1:1 for T4 and TBG. The mean serum TBG in 19 patients with hepatocellular carcinoma was 2.10 +/- 1.29 mg/100 ml; however, only 2 of these patients had serum TBG levels outside the normal range.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57964     DOI: 10.1210/jcem-42-5-907

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Use of direct thyroxine-binding globulin measurement in the evaluation of thyroid function.

Authors:  D Glinoer; M Fernandez-Deville; A M Ermans
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

2.  Macroamylasemia associated with thyroid cancer, elevated serum thyroxine-binding globulin (TBG), chronic pancreatitis and gastrointestinal polyposis.

Authors:  T Ishizuka; K Yasuda; K Kajita; S Sakata; M Kimura; Y Ito; K Miura
Journal:  Gastroenterol Jpn       Date:  1986-08

3.  [Thyroxine-binding globulin (TBG): preparation, radioimmunoassay and clinical significance (author's transl)].

Authors:  K Horn; T Kubiczek; C R Pickardt; P C Scriba
Journal:  Klin Wochenschr       Date:  1977-09-15

Review 4.  Studies on thyroxine-binding globulin.

Authors:  L Bartalena
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

5.  Thyroid and pituitary hormone responses to TRH in advanced nonalcoholic liver disease.

Authors:  D H Van Thiel; R Tarter; J S Gavaler; R R Schade; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

6.  The effect of prednisone on serum thyrotropin, thyroxine and triiodothyronine concentrations in hypothyroid patients.

Authors:  J Jensen; G Nolan; W Jubiz
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

7.  Antibody binding serum T3 in a patient with hepatocarcinoma.

Authors:  J Ordóñez-Llanos; J Rodríguez-Espinosa; J A Gómez-Gerique
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

8.  Concentration of thyroxine-binding globulin: value of direct assay.

Authors:  W A Burr; D B Ramsden; S E Evans; T Hogan; R Hoffenberg
Journal:  Br Med J       Date:  1977-02-19

9.  Clinical evaluation of thyroxine-binding globulin (TBG) as a marker of liver tumors.

Authors:  S Terui
Journal:  Eur J Nucl Med       Date:  1984

10.  The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.

Authors:  L Bartalena; F Bogazzi; G Donadel; E Martino; F Gabrielli; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.